EP1078023A4 - Lumineszierende verbindungen - Google Patents
Lumineszierende verbindungenInfo
- Publication number
- EP1078023A4 EP1078023A4 EP99915319A EP99915319A EP1078023A4 EP 1078023 A4 EP1078023 A4 EP 1078023A4 EP 99915319 A EP99915319 A EP 99915319A EP 99915319 A EP99915319 A EP 99915319A EP 1078023 A4 EP1078023 A4 EP 1078023A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- luminescent compounds
- luminescent
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Materials Engineering (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07102880A EP1849837A3 (de) | 1998-04-08 | 1999-04-07 | Lumineszierende Verbindungen |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19815659 | 1998-04-08 | ||
DE19815659A DE19815659A1 (de) | 1998-04-08 | 1998-04-08 | Reaktive Quadratsäure- und Croconsäure-Farbstoffe als Marker für Biomoleküle und Arzneistoffe |
US8382098P | 1998-05-01 | 1998-05-01 | |
US83820P | 1998-05-01 | ||
PCT/US1999/007627 WO1999051702A1 (en) | 1998-04-08 | 1999-04-07 | Luminescent compounds |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07102880A Division EP1849837A3 (de) | 1998-04-08 | 1999-04-07 | Lumineszierende Verbindungen |
EP07102880.7 Division-Into | 2007-02-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1078023A1 EP1078023A1 (de) | 2001-02-28 |
EP1078023A4 true EP1078023A4 (de) | 2003-03-26 |
EP1078023B1 EP1078023B1 (de) | 2011-01-05 |
Family
ID=26045346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99915319A Expired - Lifetime EP1078023B1 (de) | 1998-04-08 | 1999-04-07 | Lumineszierende verbindungen |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1078023B1 (de) |
AU (1) | AU3386399A (de) |
WO (1) | WO1999051702A1 (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20122672U1 (de) | 2000-09-29 | 2007-04-05 | Molecular Probes, Inc., Eugene | Modifizierte Carbocyaninfarbstoffe und deren Konjugate |
DE01975541T9 (de) | 2000-09-29 | 2006-11-16 | Molecular Probes, Inc., Eugene | Modifizierte carbocyaninfarbstoffe und deren konjugate |
US8323903B2 (en) | 2001-10-12 | 2012-12-04 | Life Technologies Corporation | Antibody complexes and methods for immunolabeling |
EP1469989B1 (de) | 2002-01-02 | 2011-12-14 | Visen Medical, Inc. | Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten |
US7282339B2 (en) | 2003-09-17 | 2007-10-16 | Invitrogen Corporation | Competitive immunoassay |
GB0323171D0 (en) * | 2003-10-03 | 2003-11-05 | Univ Coventry | Fluorescent compound |
CA2577053A1 (en) | 2004-08-13 | 2006-02-23 | Epoch Biosciences, Inc. | Phosphonate fluorescent dyes and conjugates |
US7767834B2 (en) * | 2004-08-13 | 2010-08-03 | Elitech Holding B.V. | Phosphonylated fluorescent dyes and conjugates |
WO2007028037A1 (en) | 2005-09-02 | 2007-03-08 | Visen Medical, Inc. | Biocompatible n, n-disubstituted sulfonamide-containing fluorescent dye labels |
US8173819B2 (en) | 2005-09-02 | 2012-05-08 | Visen Medical, Inc. | Nicotinic and picolinic acid derived near-infrared fluorophores |
ES2612738T3 (es) | 2005-09-02 | 2017-05-18 | Visen Medical, Inc. | Agentes de formación de imágenes fluorescentes biocompatibles |
EP1934607B1 (de) | 2005-10-13 | 2013-08-28 | Fundação D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud | Multiplex in situ immunochemische analyse |
ATE500778T1 (de) | 2005-12-22 | 2011-03-15 | Visen Medical Inc | Kombiniertes röntgen- und optisches tomographie- bildgebungssystem |
US9913917B2 (en) | 2005-12-22 | 2018-03-13 | Visen Medical, Inc. | Biocompatible fluorescent metal oxide nanoparticles |
JP2009524832A (ja) | 2006-01-24 | 2009-07-02 | ライフ テクノロジーズ コーポレーション | 検体を定量するためのデバイスおよび方法 |
US8114636B2 (en) | 2006-02-10 | 2012-02-14 | Life Technologies Corporation | Labeling and detection of nucleic acids |
EP3438131B1 (de) | 2006-02-10 | 2022-03-16 | Life Technologies Corporation | Modifizierung von oligosacchariden und etikettierung von proteinen |
US8562802B1 (en) | 2006-02-13 | 2013-10-22 | Life Technologies Corporation | Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems |
AU2007252926A1 (en) | 2006-03-23 | 2007-11-29 | Absorber Ab | Blood group antigens of different types for diagnostic and therapeutic applications |
JP5337691B2 (ja) | 2006-04-20 | 2013-11-06 | ベクトン・ディキンソン・アンド・カンパニー | 熱安定性タンパク質ならびにその作製方法および使用方法 |
US8017104B2 (en) | 2007-02-28 | 2011-09-13 | Carestream Health, Inc. | Large stoke shift dye used for optical imaging |
US8906354B2 (en) | 2007-02-28 | 2014-12-09 | Bruker Biospin Corporation | Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes |
WO2009055095A1 (en) | 2007-10-19 | 2009-04-30 | Visen Medical, Inc. | Imaging systems featuring waveguiding compensation |
WO2009092062A2 (en) | 2008-01-18 | 2009-07-23 | Visen Medical, Inc. | Fluorescent imaging agents |
AU2009223235B2 (en) | 2008-03-14 | 2014-09-11 | Merck Sharp & Dohme Corp. | Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
WO2009140541A2 (en) | 2008-05-16 | 2009-11-19 | Life Technologies Corporation | Dual labeling methods for measuring cellular proliferation |
US8864821B2 (en) | 2008-11-26 | 2014-10-21 | Visen Medical, Inc. | Methods and compositions for identifying subjects at risk of developing stent thrombosis |
US8401618B2 (en) | 2009-08-28 | 2013-03-19 | Visen Medical, Inc. | Systems and methods for tomographic imaging in diffuse media using a hybrid inversion technique |
WO2011026085A2 (en) | 2009-08-31 | 2011-03-03 | Promega Corporation | Reactive cyanine compounds |
CA2810822C (en) | 2009-09-22 | 2018-03-06 | Visen Medical, Inc. | Systems and methods for virtual index-matching of diffusive media |
WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
WO2012154885A2 (en) | 2011-05-09 | 2012-11-15 | Visen Medical, Inc. | Carbonic anhydrase targeting agents and methods of using same |
CN104245954A (zh) | 2012-03-30 | 2014-12-24 | 文森医学公司 | 细菌成像剂及其使用方法 |
CN104955484B (zh) | 2012-08-15 | 2019-01-15 | 文森医学公司 | 用于前列腺癌成像的前列腺特异性抗原药剂及其使用方法 |
US10743768B2 (en) | 2012-10-15 | 2020-08-18 | Visen Medical, Inc. | Systems, methods, and apparatus for imaging of diffuse media featuring cross-modality weighting of fluorescent and bioluminescent sources |
EP2912459A2 (de) | 2012-10-25 | 2015-09-02 | Life Technologies Corporation | Verfahren und zusammensetzungen zur enzymvermittelten stellenspezifischen radioaktiven markierung von glykoproteinen |
WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
RU2683498C2 (ru) | 2013-10-02 | 2019-03-28 | МЕДИММЬЮН, ЭлЭлСи | Нейтрализующие антитела к вирусу гриппа а и пути их применения |
US9504405B2 (en) | 2013-10-23 | 2016-11-29 | Verily Life Sciences Llc | Spatial modulation of magnetic particles in vasculature by external magnetic field |
US10542918B2 (en) | 2013-10-23 | 2020-01-28 | Verily Life Sciences Llc | Modulation of a response signal to distinguish between analyte and background signals |
BR112016015198A2 (pt) | 2013-12-31 | 2017-08-08 | Memorial Sloan Kettering Cancer Center | Sistemas, métodos e aparelho para a produção de imagens multicanal de fontes fluorescentes em tempo real |
CA2970719C (en) | 2014-12-15 | 2023-08-01 | Memorial Sloan Kettering Cancer Center | Cyclic peptides with enhanced nerve-binding selectivity, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging |
US9861710B1 (en) | 2015-01-16 | 2018-01-09 | Verily Life Sciences Llc | Composite particles, methods, and in vivo diagnostic system |
US10028659B2 (en) | 2015-03-26 | 2018-07-24 | Verily Life Sciences Llc | Aptamer-based sensors, implantable devices and detection system |
WO2017106525A1 (en) | 2015-12-15 | 2017-06-22 | Memorial Sloan Kettering Cancer Center | Imaging systems and methods for tissue differentiation, e.g., for intraoperative visualization |
CN108291989B (zh) * | 2015-12-17 | 2021-01-15 | 富士胶片株式会社 | 近红外线吸收性组合物、膜、红外线截止滤波器、固体摄像元件、红外线吸收剂及化合物 |
WO2017181176A1 (en) | 2016-04-15 | 2017-10-19 | Lcahn School Of Medicine At Mount Sinai | Tissue profiling using multiplexed immunohistochemical consecutive staining |
EP3548096A1 (de) | 2016-11-30 | 2019-10-09 | Memorial Sloan Kettering Cancer Center | Inhibitorfunktionalisierte ultrakleine nanopartikel und verfahren dafür |
WO2018183621A1 (en) | 2017-03-30 | 2018-10-04 | Life Technologies Corporation | Quantification of ngs dna by adapter sequence |
CN111970960A (zh) | 2018-03-30 | 2020-11-20 | 珀金埃尔默健康科学有限公司 | 使用短波红外(swir)投影层析成像对解剖器官和内含物进行3d重建的系统和方法 |
CN114516821B (zh) * | 2018-10-09 | 2024-02-13 | 宁波卢米蓝新材料有限公司 | 一种含有多元环的化合物、应用及有机电致发光器件 |
CN115803333A (zh) | 2020-07-02 | 2023-03-14 | 生命技术公司 | 三核苷酸帽类似物、其制备和用途 |
CN112557589B (zh) * | 2020-11-02 | 2022-02-25 | 北京理工大学 | 一种评估活性破片耦合能量时空域释放特性的方法及系统 |
EP4015004A1 (de) | 2020-12-18 | 2022-06-22 | Phi Pharma SA | Proteoglykanspezifische verzweigte peptide |
CN112851650B (zh) * | 2020-12-31 | 2022-05-31 | 山西大学 | 一种超快速检测生物硫醇荧光探针的制备方法及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996041144A2 (en) * | 1995-06-06 | 1996-12-19 | Hyperion, Inc. | Polyoxyhydrocarbyl marker products and methods for fluorescence assays |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3998943A (en) * | 1973-10-02 | 1976-12-21 | Syva Company | Double receptor fluorescent immunoassay |
US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4883867A (en) * | 1985-11-01 | 1989-11-28 | Becton, Dickinson And Company | Detection of reticulocytes, RNA or DNA |
US5101015A (en) * | 1989-04-10 | 1992-03-31 | Abbott Laboratories | Reagents for an amphetamine-class fluorescence polarization immunoassay |
-
1999
- 1999-04-07 WO PCT/US1999/007627 patent/WO1999051702A1/en active Application Filing
- 1999-04-07 EP EP99915319A patent/EP1078023B1/de not_active Expired - Lifetime
- 1999-04-07 AU AU33863/99A patent/AU3386399A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996041144A2 (en) * | 1995-06-06 | 1996-12-19 | Hyperion, Inc. | Polyoxyhydrocarbyl marker products and methods for fluorescence assays |
Non-Patent Citations (1)
Title |
---|
See also references of WO9951702A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1078023B1 (de) | 2011-01-05 |
WO1999051702A1 (en) | 1999-10-14 |
AU3386399A (en) | 1999-10-25 |
EP1078023A1 (de) | 2001-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1078023A4 (de) | Lumineszierende verbindungen | |
GB9804734D0 (en) | Compounds | |
GB0119695D0 (en) | Novel compound | |
GB9804175D0 (en) | Compounds | |
GB9805348D0 (en) | Compound | |
GB9827431D0 (en) | Novel compound | |
GB9808268D0 (en) | Compound | |
GB9808896D0 (en) | Novel compound | |
GB9801712D0 (en) | Compounds | |
GB9812522D0 (en) | Compounds | |
GB9809217D0 (en) | Compounds | |
GB9808894D0 (en) | Novel compound | |
GB9823175D0 (en) | Compound | |
GB9700398D0 (en) | Luminescent compounds | |
GB9700397D0 (en) | Luminescent compounds | |
GB9823856D0 (en) | Novel compound | |
GB9821732D0 (en) | Novel compound | |
GB9826172D0 (en) | Novel compound | |
GB9827277D0 (en) | Novel compound | |
GB9817307D0 (en) | Novel compound | |
GB9817310D0 (en) | Novel compound | |
GB9817321D0 (en) | Novel compound | |
GB9817323D0 (en) | Novel compound | |
GB9817337D0 (en) | Novel compound | |
GB9815871D0 (en) | Novel compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001107 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB IE IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030206 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 09B 23/00 B Ipc: 7G 01N 21/64 B Ipc: 7C 09K 11/06 A |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: LUMINEX CORPORATION |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: LUMINEX CORPORATION |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB IE IT LI LU NL SE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69943106 Country of ref document: DE Date of ref document: 20110217 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 69943106 Country of ref document: DE Effective date: 20110217 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2357989 Country of ref document: ES Kind code of ref document: T3 Effective date: 20110504 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110105 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110105 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
26N | No opposition filed |
Effective date: 20111006 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110430 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110430 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 69943106 Country of ref document: DE Effective date: 20111006 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110407 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110407 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 69943106 Country of ref document: DE Representative=s name: D YOUNG & CO LLP, GB Ref country code: DE Ref legal event code: R082 Ref document number: 69943106 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20180426 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20180503 Year of fee payment: 20 Ref country code: DE Payment date: 20180427 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20180425 Year of fee payment: 20 Ref country code: BE Payment date: 20180427 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20180427 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69943106 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MK Effective date: 20190406 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20190406 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MK Effective date: 20190407 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190406 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20201204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190408 |